DOJ

DOJ Investigating Sanofi Over Plavix Disclosure

DOJ Investigating Sanofi Over Plavix Disclosure

Motley Fool

Feds still zealous about off-label marketing, DoJ official says

Feds still zealous about off-label marketing, DoJ official says

Fierce Pharma

The US Department of Justice's targeting of medical speech and its public health impacts

The US Department of Justice's targeting of medical speech and its public health impacts

American Enterprise Institute

FTC, DOJ Propose to Adopt Rule Changes On Premerger Notification for Rx Companies

FTC, DOJ Propose to Adopt Rule Changes On Premerger Notification for Rx Companies

Bloomberg BNA

J&J faces new marketing probes as Risperdal settlement nears

J&J faces new marketing probes as Risperdal settlement nears

Fierce Pharma

J&J close to settling with DOJ over marketing-WSJ

J&J close to settling with DOJ over marketing-WSJ

Reuters

Ranbaxy brings in U.S. consultants as part of consent decree

Ranbaxy brings in U.S. consultants as part of consent decree

Fierce Pharma

Submitted by moderatorj on Thu, 04/26/2012 - 22:20

Diabetes: DOJ investigates Shires' DermaGraft marketing

Diabetes: DOJ investigates Shires' DermaGraft marketing

Mass Device

DOJ Subpoena May Rattle Old Skeletons in Merck’s Closet

DOJ Subpoena May Rattle Old Skeletons in Merck’s Closet

BNET Pharma

Feds Probe Cephalon For Off-Label Treanda Promotion

Feds Probe Cephalon For Off-Label Treanda Promotion

Pharmalot